Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-004305
Filing Date
2023-09-29
Accepted
2023-09-29 16:11:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 8025
  Complete submission text file 0001950047-23-004305.txt   9583
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Subject) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41331 | Film No.: 231295648
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017 917-334-0724
Adjuvant Capital GP, L.P. (Reporting) CIK: 0001935100 (see all company filings)

EIN.: 832187125 | State of Incorp.: DE
Type: 144